Analysis: Expeditors – fiduciary duty is not a crime scene
On the balance sheet, the case doesn’t hold up
From Premium’s smell of blood in October to new records: it has been a hell of a ride for Expeditors (EXPD) in recent weeks.
Since 7 November, when it disclosed a mixed Q3 23 trading update, it has gained traction without leaving a cent on the ground in terms of capital appreciation.
Stunning.
Spare a thought for its detractors: seldom more expensive, based on its forward twelve months multiples – and when it was just as pricey as it is now (click to ...
For uninterrupted access, sign in, subscribe or upgrade to The Daily News. For as little as £12 / month (£100/year), we can get you into the room where the big decisions are made.
For uninterrupted access, sign in or sign up to The Daily News, Premium or The Loadstar Enterprise Plan.
Comment on this article